Aytu Biopharma (AYTU) Other Working Capital Changes (2019 - 2026)

Aytu Biopharma (AYTU) has reported Other Working Capital Changes for 13 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Other Working Capital Changes rose 22.58% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $1.1 million, a 36.73% decrease from a year earlier, with the FY2025 full-year figure at $451000.0, up 237.08% from the prior year.
• Other Working Capital Changes was $2.0 million for Q1 2026 at Aytu Biopharma, up from $1.5 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $1.8 million in Q2 2023 and troughed at -$3.7 million in Q3 2023.
• A 5-year average of -$188588.2 and a median of -$49000.0 in 2025 frame the typical range for Other Working Capital Changes.
• Across the five-year window, Other Working Capital Changes soared 745.52% in 2022 and plunged 441.24% in 2023, its largest moves.
• Over 5 years, Other Working Capital Changes stood at $2.8 million in 2022, then slumped by 53.76% to $1.3 million in 2023, then sank by 38.47% to $798000.0 in 2024, then soared by 85.84% to $1.5 million in 2025, then soared by 36.55% to $2.0 million in 2026.
• The last three Other Working Capital Changes figures came in at $2.0 million (Q1 2026), $1.5 million (Q4 2025), and -$484000.0 (Q3 2025), per Business Quant data.